Question 0 of 18

Drug Classification  ·  Questions 1–6

Identify the pharmacological class or categorical label for each drug or receptor. Vocabulary preparation is sufficient to answer every question in this section.

Question 1 of 18  ·  Drug Classification

Chlorthalidone is classified as which of the following?

  • ALoop diuretic
  • BPotassium-sparing diuretic
  • CThiazide-type diuretic
  • DCarbonic anhydrase inhibitor

Correct Answer

C — Thiazide-type diuretic

Rationale

Chlorthalidone is a thiazide-type diuretic. Furosemide is a loop diuretic. Amiloride is a potassium-sparing diuretic. Acetazolamide is a carbonic anhydrase inhibitor.

Question 2 of 18  ·  Drug Classification

Indapamide belongs to which of the following drug classes?

  • AThiazide-like diuretics
  • BThiazide diuretics
  • CLoop diuretics
  • DPotassium-sparing diuretics

Correct Answer

A — Thiazide-like diuretics

Rationale

Indapamide is a thiazide-like diuretic, structurally distinct from but functionally similar to the thiazide diuretics. Hydrochlorothiazide is a thiazide diuretic. Torsemide is a loop diuretic. Triamterene is a potassium-sparing diuretic.

Question 3 of 18  ·  Drug Classification

Amlodipine belongs to which subclass of calcium channel blockers?

  • ANon-dihydropyridine calcium channel blockers
  • BT-type selective calcium channel blockers
  • CMixed calcium and sodium channel blockers
  • DDihydropyridine calcium channel blockers

Correct Answer

D — Dihydropyridine calcium channel blockers

Rationale

Amlodipine is a dihydropyridine calcium channel blocker. Verapamil and diltiazem are non-dihydropyridine calcium channel blockers.

Question 4 of 18  ·  Drug Classification

Clonidine and methyldopa are both classified as which of the following?

  • ADihydropyridine calcium channel blockers
  • BCentrally acting alpha-2 adrenergic receptor agonists
  • CAngiotensin receptor blockers
  • DThiazide-like diuretics

Correct Answer

B — Centrally acting alpha-2 adrenergic receptor agonists

Rationale

Clonidine and methyldopa are both centrally acting alpha-2 adrenergic receptor agonists. Amlodipine is a dihydropyridine calcium channel blocker. Losartan is an angiotensin receptor blocker. Indapamide is a thiazide-like diuretic.

Question 5 of 18  ·  Drug Classification

Doxazosin is classified as which of the following?

  • ASelective beta-1 adrenergic receptor antagonist
  • BCentrally acting alpha-2 adrenergic receptor agonist
  • CSelective alpha-1 adrenergic receptor antagonist
  • DNon-dihydropyridine calcium channel blocker

Correct Answer

C — Selective alpha-1 adrenergic receptor antagonist

Rationale

Doxazosin is a selective alpha-1 adrenergic receptor antagonist. Metoprolol is a selective beta-1 adrenergic receptor antagonist. Clonidine is a centrally acting alpha-2 adrenergic receptor agonist. Verapamil is a non-dihydropyridine calcium channel blocker.

Question 6 of 18  ·  Drug Classification

Bisoprolol and nebivolol are classified as which of the following?

  • ASelective beta-1 adrenergic receptor antagonists
  • BNonselective beta-adrenergic receptor antagonists
  • CAlpha-1 adrenergic receptor antagonists
  • DCentrally acting alpha-2 adrenergic receptor agonists

Correct Answer

A — Selective beta-1 adrenergic receptor antagonists

Rationale

Bisoprolol and nebivolol are both selective beta-1 adrenergic receptor antagonists. Propranolol is a nonselective beta-adrenergic receptor antagonist. Doxazosin is an alpha-1 adrenergic receptor antagonist. Clonidine is a centrally acting alpha-2 adrenergic receptor agonist.

Core Pharmacology  ·  Questions 7–14

Apply your understanding of drug mechanisms, pharmacokinetics, and adverse effects. Each question requires one reasoning step.

Question 7 of 18  ·  Core Pharmacology

In a 72-year-old man with blood pressure of 162/64 millimeters of mercury, systolic pressure is elevated while diastolic pressure is low, producing a wide pulse pressure. Which of the following best explains the underlying vascular mechanism producing this pattern?

  • AIncreased renin secretion from aging kidneys drives angiotensin II-mediated arteriolar constriction that selectively raises systolic blood pressure while sparing the venous system and diastolic pressure
  • BCardiac hypertrophy from years of chronic pressure overload increases stroke volume in systole while reducing ventricular filling in diastole, creating the pressure differential
  • CAge-related loss of baroreceptor sensitivity allows larger blood pressure swings during the cardiac cycle, amplifying systolic peaks while deepening diastolic troughs
  • DAge-related arterial stiffness eliminates the aortic Windkessel effect — the compliant aorta can no longer absorb stroke volume during systole or recoil during diastole, so systolic pressure rises sharply and diastolic pressure falls as reflected pulse waves return earlier in the cardiac cycle

Correct Answer

D — Age-related arterial stiffness eliminates the aortic Windkessel effect — the compliant aorta can no longer absorb stroke volume during systole or recoil during diastole, so systolic pressure rises sharply and diastolic pressure falls as reflected pulse waves return earlier in the cardiac cycle

Rationale

The Windkessel effect describes the normal role of the compliant aorta in buffering each cardiac stroke: during systole, the elastic aorta expands to store part of the stroke volume, dampening the systolic pressure rise; during diastole, elastic recoil of the stored volume maintains pressure and coronary perfusion. With aging, elastin fibers in the aortic wall fragment and are replaced by stiffer collagen; advanced glycation end products cross-link these collagen molecules further; and medial calcification adds rigidity. The stiff aorta can no longer perform this buffering — each stroke volume is transmitted directly and forcefully, producing a higher systolic peak. Simultaneously, because the arterial walls are stiff, pulse waves generated by cardiac contraction travel faster and return from peripheral reflection sites earlier — now arriving during late systole rather than diastole, augmenting systolic pressure while reducing the diastolic component. The clinical result is isolated systolic hypertension with a wide pulse pressure, which is the dominant pattern in patients over 60 years of age and a stronger predictor of cardiovascular events than diastolic blood pressure in this age group.

Question 8 of 18  ·  Core Pharmacology

An 80-year-old man with isolated systolic hypertension and established coronary artery disease has a blood pressure of 158/62 millimeters of mercury. His physician wants to lower systolic blood pressure aggressively. Which of the following best explains why reducing diastolic blood pressure below 65 to 70 millimeters of mercury in this patient carries cardiac risk?

  • ALow diastolic pressure activates baroreceptors that trigger reflex tachycardia, increasing myocardial oxygen demand in the presence of fixed coronary stenosis
  • BCoronary arteries fill predominantly during diastole — when diastolic pressure is too low, coronary perfusion pressure falls below the autoregulatory floor, impairing myocardial blood flow to areas supplied by stenosed vessels
  • CReducing diastolic pressure narrows pulse pressure, which reduces cardiac output through reduced Frank-Starling preload filling during late diastole
  • DLow diastolic pressure impairs hepatic perfusion, reducing clearance of antihypertensive drugs and causing drug accumulation that worsens blood pressure lowering in a self-amplifying cycle

Correct Answer

B — Coronary arteries fill predominantly during diastole — when diastolic pressure is too low, coronary perfusion pressure falls below the autoregulatory floor, impairing myocardial blood flow to areas supplied by stenosed vessels

Rationale

The heart is unique among organs in that most of its blood supply arrives during diastole, not systole. During systole, myocardial wall tension compresses intramural coronary vessels, reducing flow. During diastole, the relaxed myocardium allows coronary filling driven by aortic diastolic pressure. In patients with coronary artery disease, stenotic vessels already have reduced perfusion reserve and depend more acutely on adequate perfusion pressure. The coronary circulation can autoregulate blood flow across a range of perfusion pressures, but when diastolic pressure falls below approximately 65 to 70 millimeters of mercury, the autoregulatory reserve may be exceeded in territories supplied by stenotic vessels, producing myocardial ischemia. This relationship is termed the J-curve phenomenon: at very low diastolic pressures, cardiovascular event rates paradoxically rise even though overall blood pressure is lower. In elderly patients with isolated systolic hypertension and concurrent coronary artery disease, the treatment goal is to reduce systolic blood pressure while accepting that diastolic blood pressure cannot be driven below 65 to 70 millimeters of mercury without cardiac risk.

Question 9 of 18  ·  Core Pharmacology

Orthostatic hypotension is a common and clinically important problem in elderly hypertensive patients. Which of the following correctly defines orthostatic hypotension and identifies the antihypertensive drug classes that most commonly precipitate or worsen it?

  • AA fall in systolic blood pressure of at or above 20 millimeters of mercury or diastolic blood pressure of at or above 10 millimeters of mercury within 3 minutes of standing; alpha-1 blockers, loop diuretics, and calcium channel blockers are the most problematic classes
  • BA fall in systolic blood pressure of at or above 40 millimeters of mercury or diastolic blood pressure of at or above 20 millimeters of mercury on moving from sitting to standing; angiotensin receptor blockers and thiazide diuretics are the most problematic classes
  • CAny fall in blood pressure greater than 10 millimeters of mercury systolic on standing; beta-adrenergic receptor antagonists are the most problematic class because they block the compensatory tachycardia that normally maintains blood pressure on standing
  • DA fall in systolic blood pressure of at or above 20 millimeters of mercury within 3 minutes of standing occurring only when accompanied by symptoms such as dizziness; renin-angiotensin-aldosterone system inhibitors are most commonly responsible

Correct Answer

A — A fall in systolic blood pressure of at or above 20 millimeters of mercury or diastolic blood pressure of at or above 10 millimeters of mercury within 3 minutes of standing; alpha-1 blockers, loop diuretics, and calcium channel blockers are the most problematic classes

Rationale

Orthostatic hypotension is defined by consensus as a fall in systolic blood pressure of 20 millimeters of mercury or more, or a fall in diastolic blood pressure of 10 millimeters of mercury or more, within 3 minutes of moving from a supine or seated position to standing. The definition does not require symptoms — asymptomatic orthostatic hypotension is still clinically relevant because it is associated with approximately twice the risk of falls, syncope, and cardiovascular events compared with normotensive elderly individuals. Prevalence is approximately 20 percent in community-dwelling elderly patients, rising above 50 percent in institutionalized elderly. Among antihypertensive drug classes, alpha-1 blockers are the most problematic because they produce rapid venodilation and reduce the sympathetic vasoconstriction that normally compensates for postural blood pressure changes. Loop diuretics cause volume depletion that reduces venous return on standing. Calcium channel blockers dilate arterioles and impair the normal vasoconstrictor response to standing. Blood pressure must be measured in both sitting and standing positions at every visit in elderly hypertensive patients — a requirement that is often neglected in clinical practice.

Question 10 of 18  ·  Core Pharmacology

Age-related pharmacokinetic changes affect how antihypertensive drugs behave in elderly patients. Which of the following correctly describes two such changes and their clinical implications for antihypertensive drug selection and dosing?

  • AIncreased glomerular filtration rate with age accelerates renal drug clearance — drugs such as amlodipine and atenolol need higher doses in the elderly to maintain therapeutic plasma levels
  • BIncreased hepatic blood flow with age enhances first-pass metabolism — hepatically eliminated drugs such as metoprolol and labetalol achieve lower plasma levels in the elderly and require higher doses
  • CDeclining glomerular filtration rate causes renally excreted drugs such as atenolol and lisinopril to accumulate; reduced hepatic blood flow raises oral bioavailability of drugs such as metoprolol and labetalol by reducing first-pass metabolism
  • DReduced lean body mass in the elderly decreases the volume of distribution of lipophilic drugs, causing higher peak plasma levels but shorter durations of action — requiring more frequent dosing of agents such as metoprolol and propranolol

Correct Answer

C — Declining glomerular filtration rate causes renally excreted drugs such as atenolol and lisinopril to accumulate; reduced hepatic blood flow raises oral bioavailability of drugs such as metoprolol and labetalol by reducing first-pass metabolism

Rationale

Two pharmacokinetic changes are particularly relevant to antihypertensive prescribing in the elderly. First, glomerular filtration rate declines by approximately 1 milliliter per minute per year after age 40. This means that renally excreted drugs — including atenolol, lisinopril, and enalaprilat — accumulate progressively as patients age, reaching higher steady-state plasma levels than in younger patients on the same dose. For atenolol, this accumulation contributes to bradycardia, fatigue, and blocks of cardiac conduction. The Chronic Kidney Disease Epidemiology Collaboration equation should be used to estimate renal function because serum creatinine alone overestimates renal function in the elderly (reduced muscle mass generates less creatinine). Second, hepatic blood flow decreases with age, reducing the fraction of an oral dose eliminated during first-pass metabolism by the liver. This increases the bioavailability of high-extraction hepatic drugs — including metoprolol, propranolol, labetalol, and immediate-release nifedipine — so that standard oral doses produce higher plasma concentrations in elderly patients than in younger adults. An additional pharmacokinetic consideration is that lipophilic drugs (lipid-soluble drugs) have a larger apparent volume of distribution in the elderly because body fat increases relative to lean mass, and they cross the blood-brain barrier more readily, increasing central nervous system adverse effects.

Question 11 of 18  ·  Core Pharmacology

When initiating antihypertensive therapy in a frail 84-year-old patient, which of the following principles best describes the appropriate approach to dosing and titration, and why is this approach necessary?

  • AStart at the standard adult dose and titrate every 2 weeks — elderly patients often have inadequate tissue perfusion from prolonged untreated hypertension and rapid correction is required
  • BStart at double the standard dose because reduced gastrointestinal absorption in the elderly reduces drug bioavailability, requiring higher doses to achieve therapeutic plasma levels
  • CSkip the titration phase and initiate combination therapy from the outset — the elderly benefit more from two drugs at moderate doses than from one drug titrated to a high dose
  • DBegin at half the standard starting dose and titrate slowly at 4 to 6 week intervals — reduced drug clearance, impaired compensatory reflexes, and multiple drug interactions in patients taking 5 to 7 medications make elderly patients more susceptible to adverse effects from rapid dose escalation

Correct Answer

D — Begin at half the standard starting dose and titrate slowly at 4 to 6 week intervals — reduced drug clearance, impaired compensatory reflexes, and multiple drug interactions in patients taking 5 to 7 medications make elderly patients more susceptible to adverse effects from rapid dose escalation

Rationale

The start-low, go-slow principle for elderly patients reflects the intersection of several pharmacological and physiological vulnerabilities. Reduced renal and hepatic drug clearance means that standard doses produce higher plasma levels than in younger adults. Impaired baroreceptor sensitivity means that blood pressure falls cannot be adequately compensated by the usual reflex tachycardia and vasoconstriction — making blood pressure drops more pronounced and more symptomatic. Reduced autonomic reserve impairs postural responses, increasing orthostatic hypotension risk with each dose increase. The average elderly hypertensive patient takes 5 to 7 prescription medications, and each new antihypertensive adds to an existing pharmacological burden with potential for additive hypotensive effects and drug interactions. Practical dose targets in the elderly include chlorthalidone 6.25 mg, amlodipine 2.5 mg, and perindopril 2 mg as starting doses. Titration should occur no faster than every 4 to 6 weeks to allow full assessment of tolerance and stability at each dose level before proceeding to a higher one. A second agent should only be added after confirming that the first is well tolerated.

Question 12 of 18  ·  Core Pharmacology

When selecting antihypertensives for an elderly patient with mild cognitive impairment, which of the following correctly identifies drug classes associated with cognitive adverse effects and those considered cognitively neutral?

  • AAngiotensin converting enzyme inhibitors and angiotensin receptor blockers cause memory impairment by blocking angiotensin II signaling in the hippocampus; amlodipine and chlorthalidone are cognitively neutral
  • BLipophilic beta-blockers such as metoprolol and propranolol cause fatigue, sleep disturbance, and mild cognitive effects; centrally acting agents such as clonidine and methyldopa cause sedation, confusion, and depression; amlodipine, chlorthalidone, and angiotensin receptor blockers are considered cognitively neutral
  • CAll antihypertensives impair cognition in the elderly through the same mechanism of reduced cerebral perfusion; the cognitively safest approach is to avoid all antihypertensive therapy in patients with established cognitive impairment
  • DDihydropyridine calcium channel blockers cause cognitive impairment through L-type calcium channel blockade in hippocampal neurons; thiazide diuretics are cognitively neutral but loop diuretics impair memory through sodium depletion in the cortex

Correct Answer

B — Lipophilic beta-blockers such as metoprolol and propranolol cause fatigue, sleep disturbance, and mild cognitive effects; centrally acting agents such as clonidine and methyldopa cause sedation, confusion, and depression; amlodipine, chlorthalidone, and angiotensin receptor blockers are considered cognitively neutral

Rationale

The cognitive effects of antihypertensives in the elderly are clinically relevant given the high prevalence of mild cognitive impairment in this population. Lipophilic beta-adrenergic receptor antagonists — metoprolol, propranolol — cross the blood-brain barrier more readily than hydrophilic agents and cause fatigue, vivid dreams, sleep disturbance, and mild cognitive effects at high doses. These effects are amplified in the elderly because lipophilic drugs have a larger volume of distribution in aging bodies (proportionally greater adipose tissue) and reduced hepatic first-pass metabolism raises their bioavailability. Centrally acting agents — clonidine and methyldopa — directly suppress central sympathetic tone but in doing so also cause sedation, confusion, depression, and falls, as the aging brain has reduced neurotransmitter reserve. Amlodipine, chlorthalidone, and angiotensin receptor blockers do not appreciably cross the blood-brain barrier, do not suppress central neurotransmitter systems, and are classified as cognitively neutral — they are the preferred agents when cognitive protection is a treatment priority. It is worth acknowledging that hypertension itself is a major risk factor for dementia, so treating blood pressure appropriately protects cognition — the goal is to choose agents that lower blood pressure without adding cognitive burden.

Question 13 of 18  ·  Core Pharmacology

Elderly patients — particularly older women — are at higher risk of thiazide-induced hyponatremia than younger patients. Which of the following best explains the mechanism and identifies the appropriate monitoring after thiazide initiation in this population?

  • AThiazide-induced volume depletion stimulates antidiuretic hormone release, causing free water retention that dilutes serum sodium; elderly women are particularly susceptible due to lower muscle mass reducing total body solute; serum sodium should be rechecked within 2 to 4 weeks of initiation or dose increase
  • BThiazides block aldosterone receptors in the collecting duct, preventing sodium reabsorption and causing direct urinary sodium wasting; potassium should be monitored within 2 to 4 weeks and sodium only if symptoms develop
  • CThiazides inhibit sodium-glucose cotransporter 2 in the proximal tubule, increasing urinary sodium loss while retaining glucose; elderly women are at risk because they have lower baseline glucose levels
  • DThiazides directly suppress antidiuretic hormone release from the posterior pituitary, causing excessive free water excretion that concentrates serum sodium — the reverse of the hyponatremia seen in younger patients

Correct Answer

A — Thiazide-induced volume depletion stimulates antidiuretic hormone release, causing free water retention that dilutes serum sodium; elderly women are particularly susceptible due to lower muscle mass reducing total body solute; serum sodium should be rechecked within 2 to 4 weeks of initiation or dose increase

Rationale

Thiazide diuretics cause natriuresis but do not inhibit free water reabsorption in the collecting duct. The resulting volume depletion stimulates antidiuretic hormone (also called vasopressin) release from the posterior pituitary. Antidiuretic hormone promotes free water reabsorption in the collecting duct, diluting the remaining sodium and producing hyponatremia. Unlike loop diuretics — which also block the concentrating capacity of the thick ascending limb and limit antidiuretic hormone's effectiveness — thiazides act distally and do not impair antidiuretic hormone-mediated water reabsorption, making them particularly prone to causing hyponatremia. Elderly women are at elevated risk for two reasons: lower baseline muscle mass means less total body solute to buffer the dilutional effect, and estrogen sensitizes the hypothalamic thirst center and antidiuretic hormone response. Serum sodium must be rechecked within 2 to 4 weeks of initiating or increasing a thiazide in elderly patients — hyponatremia can be severe enough to cause confusion, seizures, and life-threatening complications if undetected.

Question 14 of 18  ·  Core Pharmacology

An 88-year-old frail woman with hypertension has experienced two falls in the past three months and reports progressive weakness and lightheadedness. She takes four antihypertensives. Her blood pressure is 108/62 millimeters of mercury supine and 84/50 millimeters of mercury standing. Which of the following best represents the appropriate pharmacological response?

  • AAdd fludrocortisone to raise blood pressure and reduce orthostatic hypotension while continuing all four antihypertensives — withdrawing antihypertensives in a patient with a history of hypertension carries unacceptable stroke risk
  • BIntensify the antihypertensive regimen — the falls likely reflect cerebral hypoperfusion from inadequately treated hypertension, and more aggressive lowering will reduce cardiovascular risk
  • CReduce or withdraw antihypertensive medications — in frail elderly patients experiencing falls and orthostatic hypotension attributable to over-treatment, the benefit-risk calculation favors reducing therapy to improve quality of life and functional status
  • DSwitch all four antihypertensives to intravenous formulations to allow precise dose titration and avoid the variable oral absorption contributing to the orthostatic hypotension

Correct Answer

C — Reduce or withdraw antihypertensive medications — in frail elderly patients experiencing falls and orthostatic hypotension attributable to over-treatment, the benefit-risk calculation favors reducing therapy to improve quality of life and functional status

Rationale

This patient's clinical picture — supine blood pressure of 108/62 falling to 84/50 on standing, with recurrent falls and weakness — represents antihypertensive over-treatment. In a frail 88-year-old, the benefit-risk calculation for intensive blood pressure lowering shifts substantially. The absolute cardiovascular benefit of pharmacological blood pressure reduction diminishes with advancing frailty and short life expectancy, while the harms from falls — hip fractures, hospitalization, functional decline, loss of independence — become proportionally more consequential. De-prescribing (the planned and supervised reduction or withdrawal of medications) is appropriate and evidence-supported in this setting. The correct approach is to systematically withdraw or reduce antihypertensives, starting with the agent most likely to be causing orthostatic hypotension (typically an alpha-1 blocker, loop diuretic, or centrally acting agent if present), reassessing functional status and blood pressure at each step. The treatment goal in frail elderly patients shifts toward symptom management, fall prevention, and quality of life rather than cardiovascular event reduction targets designed for non-frail populations.

Clinical Correlations  ·  Questions 15–18

Apply pharmacological knowledge to clinical scenarios. Each vignette presents a patient situation; the question tests mechanism of action or drug selection.

Question 15 of 18  ·  Clinical Correlations

A 74-year-old woman with no prior cardiovascular disease, chronic kidney disease, or diabetes has a blood pressure of 158/72 millimeters of mercury on three separate visits. She is otherwise healthy and active. Her physician wants to initiate antihypertensive monotherapy. Which of the following identifies the most appropriate first-line drug class choices for this presentation, and explains why renin-angiotensin-aldosterone system inhibitors are less effective as initial monotherapy in this population?

  • ABeta-adrenergic receptor antagonists and alpha-1 blockers — they address the sympathetic overactivation and peripheral resistance that characterize isolated systolic hypertension in the elderly
  • BThiazide-like diuretics and dihydropyridine calcium channel blockers — elderly isolated systolic hypertension is characteristically low-renin and volume-dependent, making these classes more effective as monotherapy than renin-angiotensin-aldosterone system inhibitors, which are less potent in low-renin states
  • CAngiotensin converting enzyme inhibitors and angiotensin receptor blockers — these are universally first-line across all hypertension subtypes and age groups because they address the underlying renin-angiotensin-aldosterone system activation that causes all forms of hypertension
  • DLoop diuretics and centrally acting agents — loop diuretics are preferred over thiazides in the elderly because of superior blood pressure lowering, and centrally acting agents reduce the sympathetic drive to the stiff arterial wall

Correct Answer

B — Thiazide-like diuretics and dihydropyridine calcium channel blockers — elderly isolated systolic hypertension is characteristically low-renin and volume-dependent, making these classes more effective as monotherapy than renin-angiotensin-aldosterone system inhibitors, which are less potent in low-renin states

Rationale

Elderly patients with isolated systolic hypertension typically have low-renin, volume-dependent hypertension driven by arterial stiffness and sodium retention rather than by renin-angiotensin-aldosterone system activation. Thiazide-like diuretics — particularly chlorthalidone and indapamide — reduce volume and address this mechanism directly. They are supported by major outcome trial evidence specifically in elderly isolated systolic hypertension. Dihydropyridine calcium channel blockers such as amlodipine lower systolic blood pressure effectively through arteriolar vasodilation that operates independently of renin-angiotensin-aldosterone system activity, making them equally effective in low-renin states. Renin-angiotensin-aldosterone system inhibitors are less potent as monotherapy in this population precisely because there is less active renin-angiotensin-aldosterone system to inhibit — they achieve better results when combined with a diuretic or calcium channel blocker, or when a compelling indication such as chronic kidney disease with proteinuria, heart failure, or diabetic nephropathy is present. Beta-adrenergic receptor antagonists are also less effective for systolic blood pressure reduction in elderly isolated systolic hypertension and are not preferred unless a compelling indication exists.

Question 16 of 18  ·  Clinical Correlations

An 80-year-old woman on chlorthalidone 12.5 mg daily has her dose increased to 25 mg for inadequate blood pressure control. Eight days later she presents with confusion, fatigue, and nausea. Her serum sodium is 126 mEq/L (normal 135 to 145 mEq/L). Which of the following best explains the mechanism by which chlorthalidone produced this electrolyte abnormality in this patient?

  • AChlorthalidone directly inhibits sodium reabsorption in the collecting duct, producing urinary sodium wasting that lowers serum concentration without involving free water
  • BChlorthalidone blocks aldosterone receptors, causing sodium excretion and potassium retention; the hyponatremia is a direct consequence of mineralocorticoid receptor blockade
  • CChlorthalidone stimulates renin secretion, which raises angiotensin II and causes systemic vasoconstriction that dilutes plasma sodium by reducing renal perfusion
  • DChlorthalidone-induced volume depletion triggers antidiuretic hormone release, causing free water retention in the collecting duct that dilutes serum sodium; elderly women are especially vulnerable because lower lean body mass reduces total body sodium stores

Correct Answer

D — Chlorthalidone-induced volume depletion triggers antidiuretic hormone release, causing free water retention in the collecting duct that dilutes serum sodium; elderly women are especially vulnerable because lower lean body mass reduces total body sodium stores

Rationale

Chlorthalidone blocks the sodium-chloride cotransporter in the distal convoluted tubule, causing natriuresis. However, it does not block free water reabsorption in the collecting duct — that capacity remains intact and is governed by antidiuretic hormone. The volume depletion caused by natriuresis is sensed by hypothalamic osmoreceptors and baroreceptors, which trigger antidiuretic hormone release from the posterior pituitary. Antidiuretic hormone promotes free water reabsorption in the collecting duct through aquaporin channels, expanding intravascular volume but diluting the remaining sodium — the classic dilutional hyponatremia. This is why thiazides (and thiazide-like agents) cause hyponatremia while loop diuretics, which block the thick ascending limb and impair the countercurrent concentrating mechanism, generally do not. Elderly women are at particular risk for two reasons: lower lean body mass reduces total body solute available to buffer the dilutional effect, and estrogen enhances antidiuretic hormone sensitivity. A serum sodium of 126 mEq/L with neurological symptoms (confusion) requires prompt management — the immediate step is to hold chlorthalidone and address fluid and sodium balance, with cautious monitoring of sodium correction to avoid osmotic demyelination.

Question 17 of 18  ·  Clinical Correlations

An 83-year-old man with a Clinical Frailty Scale score of 7 and hypertension takes four antihypertensive medications and has experienced three falls in the past two months. In clinic, his blood pressure is 102/58 millimeters of mercury supine and 78/44 millimeters of mercury standing, with onset of lightheadedness on rising. His blood pressure target was set at below 130/80 millimeters of mercury several years ago. Which of the following best represents the pharmacologically appropriate response?

  • ASystematically reduce or withdraw antihypertensives starting with the agents most likely to cause orthostatic hypotension — the benefit-risk calculation in a very frail patient experiencing falls has shifted toward reducing medication burden and improving functional status
  • BAdd midodrine to raise standing blood pressure while continuing all four antihypertensives — the blood pressure target below 130/80 must be maintained regardless of frailty status because evidence shows cardiovascular benefit across all frailty levels
  • CSwitch all agents to long-acting formulations — the falls are caused by blood pressure variability between doses, and sustained-release formulations will smooth blood pressure throughout the day
  • DIncrease the antihypertensive doses further — the falls are likely from neurological causes unrelated to blood pressure, and reducing antihypertensives risks allowing hypertension to damage the cerebral vasculature

Correct Answer

A — Systematically reduce or withdraw antihypertensives starting with the agents most likely to cause orthostatic hypotension — the benefit-risk calculation in a very frail patient experiencing falls has shifted toward reducing medication burden and improving functional status

Rationale

This patient's blood pressures — 102/58 supine dropping to 78/44 standing — and his recurrent falls represent antihypertensive over-treatment in a very frail elderly man. A Clinical Frailty Scale score of 7 indicates severe frailty, and the evidence base for intensive blood pressure targets was derived from trials that excluded or underrepresented patients with this degree of frailty. In frail elderly patients, the absolute cardiovascular benefit of tight blood pressure control is diminished, while the harms — falls, hip fractures, hospitalization, and loss of independence — become dominant clinical concerns. The appropriate approach is de-prescribing: systematically reducing or withdrawing antihypertensives in a planned, supervised manner, starting with agents most likely to cause orthostatic hypotension such as alpha-1 blockers, loop diuretics, and centrally acting agents. The blood pressure target should be individualized, and for very frail patients, avoiding symptomatic hypotension and falls takes priority over achieving a specific numerical goal. This approach is not abandoning care — it is recognizing that quality of life and functional independence are the appropriate primary outcomes in this patient.

Question 18 of 18  ·  Clinical Correlations

A 78-year-old man with isolated systolic hypertension and a history of two coronary artery stent placements has a blood pressure of 158/61 millimeters of mercury. His physician wants to reduce systolic blood pressure more aggressively. After increasing amlodipine and adding chlorthalidone, his blood pressure is now 142/58 millimeters of mercury. He develops new exertional chest tightness. Which of the following best explains this development and its pharmacological implication?

  • AChlorthalidone has reduced plasma volume to the point of reducing cardiac preload and stroke volume, causing the chest tightness through reduced coronary blood flow velocity during systole
  • BAmlodipine at high doses causes coronary artery spasm by depleting calcium from vascular smooth muscle cells adjacent to the stents
  • CReducing diastolic pressure to 58 millimeters of mercury has impaired coronary perfusion in territories supplied by the stented vessels — coronary arteries fill during diastole, and below approximately 65 to 70 millimeters of mercury in a patient with coronary artery disease, perfusion pressure may be insufficient to maintain adequate myocardial blood flow
  • DThe combination of amlodipine and chlorthalidone has lowered systolic blood pressure enough to reduce coronary driving pressure during systole, when right coronary artery filling primarily occurs in elderly patients

Correct Answer

C — Reducing diastolic pressure to 58 millimeters of mercury has impaired coronary perfusion in territories supplied by the stented vessels — coronary arteries fill during diastole, and below approximately 65 to 70 millimeters of mercury in a patient with coronary artery disease, perfusion pressure may be insufficient to maintain adequate myocardial blood flow

Rationale

This case illustrates the J-curve phenomenon — the observation that at very low diastolic blood pressures, cardiovascular events paradoxically increase despite lower overall blood pressure. The mechanism is physiologically straightforward: unlike most organs, the heart receives the majority of its blood supply during diastole, when the myocardium relaxes and intramural vascular compression is absent. The driving pressure for coronary filling is aortic diastolic pressure. In patients with normal coronary arteries, autoregulation maintains myocardial perfusion across a wide range of perfusion pressures. In patients with coronary artery disease — including stented vessels with residual luminal irregularities or regions of microvascular disease — the autoregulatory reserve is reduced, and perfusion becomes more dependent on driving pressure. When diastolic blood pressure falls below approximately 65 to 70 millimeters of mercury in such a patient, coronary perfusion in vulnerable territories may fall below the threshold for adequate oxygen delivery, particularly during exercise when demand increases. The appropriate pharmacological response is to accept a higher systolic blood pressure target in this patient — reducing antihypertensive intensity to restore diastolic pressure to a safer range — rather than continuing to chase a systolic target at the expense of coronary perfusion.